You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023314024
Dec 20237709
Jan 20243003
Feb 20244407
Mar 20245406
Apr 20243807
May 20242601
Jun 20241608
Jul 20241205
Aug 20243004
Sep 20243603
Oct 20242607
Nov 20243008
Dec 202422011
Jan 202516011
Feb 2025804
Mar 2025008
Apr 2025001
May 2025006
Jun 2025002
Total7790135